Prelude Capital Management, LLC Atri Cure, Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $714,305 - $956,627	-25,321 Reduced 78.0%	7,143 $217,000
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $684,146 - $896,918	20,738 Added 176.85%	32,464 $1.16 Million
Q3 2023 Nov 14, 2023	BUY	$41.12 - $57.73 $154,899 - $217,468	3,767 Added 47.33%	11,726 $513,000
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $321,861 - $394,766	7,959 New	7,959 $392,000
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $172,790 - $244,889	5,161 Added 71.67%	12,362 $548,000
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $19,431 - $26,730	-508 Reduced 6.59%	7,201 $282,000
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $270,585 - $508,871	7,709 New	7,709 $315,000
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $188,944 - $234,873	-3,290 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $14,899 - $20,477	235 Added 7.69%	3,290 $229,000
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $71,358 - $86,993	-1,030 Reduced 25.21%	3,055 $212,000
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $261,971 - $327,535	4,085 New	4,085 $324,000
Q1 2020 May 15, 2020	SELL	$24.49 - $43.84 $955 - $1,709	-39 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $31,638 - $42,750	-1,315 Reduced 97.12%	39 $1,000
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $17,452 - $23,837	733 Added 118.04%	1,354 $34,000
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $43,523 - $49,829	-1,621 Reduced 72.3%	621 $19,000
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $47,088 - $59,511	1,785 Added 390.59%	2,242 $60,000
Q4 2018 Feb 14, 2019	BUY	$26.66 - $34.85 $6,265 - $8,189	235 Added 105.86%	457 $14,000
Q3 2018 Nov 14, 2018	BUY	$27.62 - $35.58 $386 - $498	14 Added 6.73%	222 $8,000
Q2 2018 Aug 14, 2018	SELL	$19.65 - $30.28 $391,624 - $603,480	-19,930 Reduced 98.97%	208 $6,000
Q1 2018 May 15, 2018	BUY	$15.05 - $21.03 $16,344 - $22,838	1,086 Added 5.7%	20,138 $413,000
Q4 2017 Feb 14, 2018	BUY	$17.69 - $23.44 $85,619 - $113,449	4,840 Added 34.06%	19,052 $348,000
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $284,240 - $344,356	14,212	14,212 $318,000

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

Vanguard Group Inc Valley Forge, PA

4.66M
Shares

$142 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$140 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

3.97M
Shares

$121 Million
0.04% of portfolio
Hood River Capital Management LLC Palm Beach Gardens, FL

2.83M
Shares

$86.1 Million
1.47% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.79M
Shares

$84.8 Million
0.5% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.41B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account